Insights into the initiation of type 2 immune responses

被引:131
作者
Oliphant, Chris J. [1 ]
Barlow, Jillian L. [1 ]
McKenzie, Andrew N. J. [1 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
关键词
allergens; interleukin-25; interleukin-33; innate lymphoid cells; nuocytes; T helper type 2 cells; thymic stromal lymphopoietin; type; 2; responses; THYMIC STROMAL LYMPHOPOIETIN; INFLAMMATORY DENDRITIC CELLS; HUMAN EPITHELIAL-CELLS; IN-VITRO DEVELOPMENT; ADAPTIVE IMMUNITY; NALP3; INFLAMMASOME; IL-4; PRODUCTION; CUTTING EDGE; MANSONI EGGS; CYTOKINE;
D O I
10.1111/j.1365-2567.2011.03499.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Type 2 immune responses, characterized by the differentiation of CD4(+) T helper type 2 (Th2) cells and the production of the type 2 cytokines interleukin-4 (IL-4), IL-5, IL-9 and IL-13, are associated with parasitic helminth infections and inflammatory conditions such as asthma and allergies. Until recently the initiating factors associated with type 2 responses had been poorly understood. This review addresses the recent advances in identifying the diverse range of antigens/allergens associated with type 2 responses and the function, expression and sources of type-2-initiating cytokines (thymic stromal lymphopoietin, IL-25 and IL-33). We also discuss the latest findings regarding innate lymphoid cells, such as nuocytes, as early sources of type 2 cytokines and their importance in protective immunity to helminth infections. These developments represent major breakthroughs in our understanding of type 2 immunity, and highlight the increased complexity existing between the innate and adaptive arms of these responses. These additional steps in the type 2 immune pathway also offer potential targets for therapeutic intervention.
引用
收藏
页码:378 / 385
页数:8
相关论文
共 50 条
  • [41] Tissue-Resident Th2 Cells in Type 2 Immunity and Allergic Diseases
    Mannion, Jenny M.
    Rahimi, Rod A.
    IMMUNOLOGICAL REVIEWS, 2025, 330 (01)
  • [42] Dendritic cells and airway epithelial cells at the interface between innate and adaptive immune responses
    Hammad, H.
    Lambrecht, B. N.
    ALLERGY, 2011, 66 (05) : 579 - 587
  • [43] Information flow in the spatiotemporal organization of immune responses
    Huang, Jessica Y.
    Lyons-Cohen, Miranda R.
    Gerner, Michael Y.
    IMMUNOLOGICAL REVIEWS, 2022, 306 (01) : 93 - 107
  • [44] Innate and adaptive immune responses to fungi in the airway
    Bartemes, Kathleen R.
    Kita, Hirohito
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (02) : 353 - 363
  • [45] Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis
    Haddad, El-Bdaoui
    Cyr, Sonya L.
    Arima, Kazuhiko
    McDonald, Robert A.
    Levit, Noah A.
    Nestle, Frank O.
    DERMATOLOGY AND THERAPY, 2022, 12 (07) : 1501 - 1533
  • [46] Schistosoma Infection and Schistosoma-Derived Products Modulate the Immune Responses Associated with Protection against Type 2 Diabetes
    Tang, Chun-Lian
    Liu, Zhi-Ming
    Gao, Yan Ru
    Xiong, Fei
    FRONTIERS IN IMMUNOLOGY, 2018, 8
  • [47] Th2-type innate immune responses mediated by natural helper cells
    Koyasu, Shigeo
    Moro, Kazuyo
    TRANSLATIONAL IMMUNOLOGY IN ASIA-OCEANIA, 2013, 1283 : 43 - 49
  • [48] Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses
    Sasaki, Eita
    Asanuma, Hideki
    Momose, Haruka
    Furuhata, Keiko
    Mizukami, Takuo
    Hamaguchi, Isao
    PLOS PATHOGENS, 2021, 17 (08)
  • [49] Natural killer cell-dendritic cell crosstalk in the initiation of immune responses
    Walzer, T
    Dalod, M
    Vivier, E
    Zitvogel, L
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 : S49 - S59
  • [50] Immune responses in neonates
    Basha, Saleem
    Surendran, Naveen
    Pichichero, Michael
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (09) : 1171 - 1184